Trials / Completed
CompletedNCT02192788
Phase II Study of SBRT as Treatment for Oligometastases in Prostate Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 68 (actual)
- Sponsor
- Grupo de Investigación Clínica en Oncología Radioterapia · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to probe the effect of SBRT as a treatment oligometastases of prostate cancer, regardless of basal treatment received, and I know the response, biochemical control, the progression-free survival as well as their impact on quality of life. Primary Objective: Local and symptomatic oligometastases Control of prostate cancer treated by SBRT. Secondary Objectives: Analyzing biochemical progression rates, progression-free survival, chemotherapy-free survival and overall survival. Analyze toxicities and quality of life of patients before and after treatment
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Stereotactic Body Radiation Therapy for Oligometastases |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2021-07-01
- Completion
- 2021-07-01
- First posted
- 2014-07-17
- Last updated
- 2021-11-19
Locations
22 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT02192788. Inclusion in this directory is not an endorsement.